PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Joseph Bolen |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Chief Scientific Officer |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
PureTech Health plc |
||||
b) |
LEI |
N/A |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||
b) |
Nature of the transaction |
Pursuant to the terms of his Employment Agreement dated October 19, 2016, on December 21, 2016 PureTech Health plc granted a share option to Joseph Bolen in respect of 309,344 Ordinary Shares. The option will vest in the following manner: 25% to vest on October 19, 2017, and remaining 75% shall vest in equal semi-annual instalments over the three years following October 19, 2017; provided that the option holder continues to be employed by PureTech Health plc on each such vesting date. The option has an exercise price of 117 pence per share. |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information
|
N/A |
||||
e) |
Date of the transaction |
2016 December 21 |
||||
f) |
Place of the transaction |
Outside a trading venue |